跳至主要内容
临床试验/CTRI/2024/06/069126
CTRI/2024/06/069126尚未招募4 期

A Randomized Controlled Open Label Prospective Study to Assess Efficacy and Safety of Intravenous Labetalol Vs Intravenous Glyceryl Trinitrate in the Management of Hypertensive Crisis - NI

KPC Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.SBP =180 mm Hg / DBP =120 mm Hg with evidence of acute end organ damage
  • 2.Patient above 18 years of age.
  • 3.Patient / legally acceptable representative of the patient who are willing to provide informed written consent.

排除标准

  • COPD, Bradycardia , Pregnancy ,LVEF less than 35% , recent use of any intravenous beta blockers or antihypertensives or phosphodiesterase inhibitors.

研究者

发起方
KPC Medical College and Hospital

相似试验